UK markets closed

Zevra Therapeutics, Inc. (1GDA.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
4.6200-0.1000 (-2.12%)
At close: 08:04AM CEST
Currency in EUR

Valuation measures4

Market cap (intra-day) 195.89M
Enterprise value 173.58M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)6.55
Price/book (mrq)3.43
Enterprise value/revenue 6.79
Enterprise value/EBITDA -1.98

Trading information

Stock price history

Beta (5Y monthly) 1.87
52-week change 322.28%
S&P500 52-week change 326.43%
52-week high 36.4500
52-week low 33.8200
50-day moving average 34.9746
200-day moving average 34.8053

Share statistics

Avg vol (3-month) 318
Avg vol (10-day) 3N/A
Shares outstanding 541.85M
Implied shares outstanding 642.38M
Float 836.09M
% held by insiders 18.39%
% held by institutions 130.89%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in USD.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin -178.47%
Operating margin (ttm)-598.13%

Management effectiveness

Return on assets (ttm)-27.75%
Return on equity (ttm)-82.27%

Income statement

Revenue (ttm)27.71M
Revenue per share (ttm)0.74
Quarterly revenue growth (yoy)19.00%
Gross profit (ttm)N/A
EBITDA -56.08M
Net income avi to common (ttm)-49.45M
Diluted EPS (ttm)-1.2100
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)52.72M
Total cash per share (mrq)1.26
Total debt (mrq)44.29M
Total debt/equity (mrq)90.72%
Current ratio (mrq)2.10
Book value per share (mrq)1.17

Cash flow statement

Operating cash flow (ttm)N/A
Levered free cash flow (ttm)N/A